Home » Stocks » Unity Biotechnology

Unity Biotechnology, Inc. (UBX)

Stock Price: $4.07 USD -0.06 (-1.33%)
Updated Oct 27, 2020 12:25 PM EDT - Market open

Stock Price Chart

Key Info

Market Cap 211.54M
Revenue (ttm) n/a
Net Income (ttm) -86.44M
Shares Out 52.04M
EPS (ttm) -1.85
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 27, 2020
Last Price $4.07
Previous Close $4.12
Change ($) -0.06
Change (%) -1.33%
Day's Open 4.15
Day's Range 4.01 - 4.15
Day's Volume 172,069
52-Week Range 2.72 - 15.44

More Stats

Market Cap 211.54M
Enterprise Value 127.33M
Earnings Date (est) Nov 4, 2020
Ex-Dividend Date n/a
Shares Outstanding 52.04M
Float 26.63M
EPS (basic) -1.85
EPS (diluted) -1.85
FCF / Share -1.58
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 3.31M
Short Ratio 3.08
Short % of Float 12.43%
Beta -0.16
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 1.95
Revenue n/a
Operating Income -96.40M
Net Income -86.44M
Free Cash Flow -78.41M
Net Cash 84.21M
Net Cash / Share 1.62
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -36.94%
ROE -72.24%
ROIC -71.50%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (6)

Buy 1
Overweight 0
Hold 5
Underweight 0
Sell 0

Analyst Consensus: Overweight

Price Target

(39.48% upside)
Current: $4.07
Target: 5.67
*Average 12-month price target from 6 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Operating Income-91.00-74.92-46.99-18.84
Net Income-82.18-76.40-44.66-30.40
Shares Outstanding43.6228.273.202.66
Earnings Per Share-1.88-2.70-13.97-11.42
Operating Cash Flow-72.42-56.62-38.36-16.40
Capital Expenditures-1.59-1.26-1.69-2.24
Free Cash Flow-74.01-57.89-40.05-18.64
Cash & Equivalents12917287.0689.74
Net Cash / Debt12917287.0689.74
Book Value121161-83.11-41.54
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Unity Biotechnology, Inc.
Country United States
Employees 100
CEO Anirvan Ghosh

Stock Information

Ticker Symbol UBX
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: UBX
IPO Date May 3, 2018


Unity Biotechnology, a biotechnology company, engages in the research and development of therapeutics to extend human health span. The company's lead drug candidates include UBX0101 that is in Phase 1 clinical study for musculoskeletal disease; and UBX1967 for ophthalmologic diseases. It is also developing programs in pulmonary disorders. The company was formerly known as Forge, Inc. and changed its name to Unity Biotechnology, Inc. in January 2015. Unity Biotechnology, Inc. was founded in 2009 and is headquartered in Brisbane, California.